Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Wiesner
K V Menon

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 2, 2001
Late hepatic allograft dysfunctionR H Wiesner, K V Menon
Journal of Clinical Gastroenterology|February 1, 1986
Does propranolol precipitate hepatic encephalopathy?R H Wiesner
Transplantation Proceedings|June 1, 1991
Selective bowel decontamination for infection prophylaxis in liver transplantation patientsR H Wiesner
Clinical Chemistry|November 1, 1994
Advances in diagnosis, prevention, and management of hepatic allograft rejectionR H Wiesner
Hepatology (Baltimore, Md.)|May 1, 1992
Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted?R H Wiesner
Mayo Clinic Proceedings|October 1, 1994
Current concepts in primary sclerosing cholangitisR H Wiesner
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1996
Is hepatic histology the true gold standard in diagnosing acute hepatic allograft rejection?R H Wiesner
Transplantation Proceedings|June 1, 1991
Acute fulminant hepatic failureR H Wiesner
Mayo Clinic Proceedings|June 11, 1998
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history modelsR H Wiesner
Best Practice & Research. Clinical Gastroenterology|August 9, 2001
Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of diseaseR H Wiesner
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 2, 2001
Late hepatic allograft dysfunctionR H Wiesner, K V Menon
Journal of Clinical Gastroenterology|February 1, 1986
Does propranolol precipitate hepatic encephalopathy?R H Wiesner
Transplantation Proceedings|June 1, 1991
Selective bowel decontamination for infection prophylaxis in liver transplantation patientsR H Wiesner
Clinical Chemistry|November 1, 1994
Advances in diagnosis, prevention, and management of hepatic allograft rejectionR H Wiesner
Hepatology (Baltimore, Md.)|May 1, 1992
Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted?R H Wiesner
Mayo Clinic Proceedings|October 1, 1994
Current concepts in primary sclerosing cholangitisR H Wiesner
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1996
Is hepatic histology the true gold standard in diagnosing acute hepatic allograft rejection?R H Wiesner
Transplantation Proceedings|June 1, 1991
Acute fulminant hepatic failureR H Wiesner
Mayo Clinic Proceedings|June 11, 1998
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history modelsR H Wiesner
Best Practice & Research. Clinical Gastroenterology|August 9, 2001
Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of diseaseR H Wiesner
Pageof 36